35 hasil untuk "Lin, Shu-Fu"
Menampilkan 1–20 · 0,62 detik · RSS
-
Artikel Jurnal Teks lengkap
Epithelial–Mesenchymal Transition Enhances Response to Oncolytic Herpesviral Therapy Through Nectin-1
Cancers exhibiting epithelial–mesenchymal transition (EMT) are associated with aggressive behavior and increased metastatic potential. Therapies that are able to target EMT would have significant clinical value. Nectin-1 is a cell surface herpes simplex virus type 1 (HSV-1) receptor that also forms…
-
Artikel Jurnal Teks lengkap
Maternal and fetal outcomes of pregnant women with type 1 diabetes, a national population study
Pregnancy in women with type 1 diabetes is associated with poor maternal and neonatal outcomes. However, the risk of these outcomes has never been evaluated in an Asian national population. In this work, we report the maternal and fetal outcomes of pregnant women with type 1 diabetes in Taiwan. A…
-
Artikel Jurnal Teks lengkap
Risk Factors and Prognosis for Metastatic Follicular Thyroid Cancer
BACKGROUND: Follicular thyroid cancer (FTC) is the second most common malignancy of thyroid. About 7%–23% of patients with FTC have distant metastasis. The aim of this study was to investigate the risk factors associated with distant metastasis and the impact of distant metastasis on survival in…
-
Artikel Jurnal Teks lengkap
Study of TCM clinical records based on LSA and LDA SHTDT model
Description of syndromes and symptoms in traditional Chinese medicine are extremely complicated. The method utilized to diagnose a patient's syndrome more efficiently is the primary aim of clinical health care workers. In the present study, two models were presented concerning this issue. The first…
-
Artikel Jurnal Teks lengkap
Activity of roniciclib in medullary thyroid cancer
Altered cyclin-dependent kinase activity is observed in many human malignancies. Cyclin-dependent kinases that promote cell cycle progression may be promising targets in the treatment of cancer. The therapeutic effects of roniciclib, a cyclin-dependent kinase inhibitor for medullary thyroid cancer…
-
Artikel Jurnal Teks lengkap
Effects of roniciclib in preclinical models of anaplastic thyroid cancer
Many human cancers have altered cyclin-dependent kinase activity. Inhibition of cyclin-dependent kinases may arrest cell cycle progression and represents an important strategy in the treatment of malignancies. We evaluated the therapeutic effects of roniciclib, a cyclin-dependent kinase inhibitor…
-
Artikel Jurnal Teks lengkap
A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer
BACKGROUND: We explored the therapeutic effects of dinaciclib, a cyclin-dependent kinase (CDK) inhibitor, in the treatment of thyroid cancer. MATERIALS AND METHODS: Seven cell lines originating from three pathologic types of thyroid cancer (papillary, follicular and anaplastic) were studied. The…
-
Artikel Jurnal Teks lengkap
Potent effects of roniciclib alone and with sorafenib against well-differentiated thyroid cancer
Activation of cyclin-dependent kinase activity is frequently observed in many human cancers; therefore, cyclin-dependent kinases that promote cell cycle transition and cell proliferation may be potential targets in the treatment of malignancy. The therapeutic effects of roniciclib, a…
-
Artikel Jurnal Teks lengkap
Targeting Ataxia Telangiectasia-Mutated and Rad3-Related for Anaplastic Thyroid Cancer
Background: Anaplastic thyroid cancer (ATC) is one of the most aggressive human malignancies and has a poor prognosis. Ataxia telangiectasia mutated and Rad3 related (ATR) is a key regulator for the DNA damage response and a potential target to treat cancer. Methods: We assessed the efficacy of BAY…
-
Artikel Jurnal Teks lengkap
Utility of a Histone Deacetylase Inhibitor (PXD101) for Thyroid Cancer Treatment
BACKGROUND: We evaluated the therapeutic effects of the histone deacetylase inhibitor PXD101 alone and in combination with conventional chemotherapy in treating thyroid cancer. METHODOLOGY/PRINCIPAL FINDINGS: We studied eight cell lines from four types of thyroid cancer (papillary, follicular…
-
Artikel Jurnal Teks lengkap
The efficacy of radioactive iodine for the treatment of well-differentiated thyroid cancer with distant metastasis
OBJECTIVE: Radioactive iodine ((131)I) has been used as a treatment for high-risk well-differentiated thyroid cancer after thyroidectomy. The aim of this study was to evaluate the long-term follow-up results after using high accumulated doses of (131)I (>600 mCi) for the treatment of…
-
Artikel Jurnal Teks lengkap
Therapeutic inhibition of polo‐like kinases in anaplastic thyroid cancer
Polo‐like kinases (PLKs) are potent regulators of cell proliferation and cell survival. Polo‐like kinases are potential targets in the treatment of anaplastic thyroid cancer (ATC), a rare but deadly disease. The therapeutic effects of volasertib, a PLK inhibitor, was evaluated for the treatment of…
-
Artikel Jurnal Teks lengkap
Prognosis of Multifocal Papillary Thyroid Carcinoma
This study was to investigate the clinical features and therapeutic outcomes of multifocal papillary thyroid microcarcinoma (PTMC). A total of 2,418 papillary thyroid carcinoma (PTC) patients had undergone thyroidectomy in one medical center between 1977 and 2010. There were 483 (20.0%) diagnosed…
-
Artikel Jurnal Teks lengkap
Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy
BACKGROUND: We assessed the utility of the dual PI3K/mTOR inhibitor NVP-BEZ235 (BEZ235) as single agent therapy and in combination with conventional chemotherapy for thyroid cancer. METHODOLOGY/PRINCIPAL FINDINGS: Eight cell lines from four types of thyroid cancer (papillary, follicular…
-
Artikel Jurnal Teks lengkap
Long-term follow-up of papillary and follicular thyroid carcinomas with bone metastasis
The aims of this study were to investigate papillary and follicular thyroid carcinomas with bone metastasis in various clinical presentations and to determine the prognostic factors after multimodality treatment. A retrospective analysis was performed of 3,120 patients with papillary and follicular…
-
Artikel Jurnal Teks lengkap
Risk factors and outcomes of metastatic poorly differentiated thyroid carcinoma
BACKGROUND: Poorly differentiated thyroid carcinoma (PDTC) is a rare and aggressive form of thyroid cancer. Distant metastasis occurs frequently in PDTC. AIM: To determine factors associated with distant metastasis and the effects of metastasis, either diagnosed on initial presentation or…
-
Artikel Jurnal Teks lengkap
Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer
In the past three decades, the thyroid cancer incidence has surged globally. Herein, the Taiwan National Health Insurance database was used to identify thyroid cancer patients and to estimate the prevalence and incidence of thyroid cancer during 1997-2012. The Taiwan Cancer Registry and the…
-
Artikel Jurnal Teks lengkap
Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer
SIMPLE SUMMARY: Adavosertib is a first-in-class Wee1 inhibitor that has demonstrated activity against certain cancers. We evaluated the effects of adavosertib in treating differentiated thyroid cancer (DTC) using four DTC cell lines (BHP7-13, K1, FTC-133, FTC-238). Adavosertib accumulated cells in…
-
Artikel Jurnal Teks lengkap
Targeting PLKs as a Therapeutic Approach to Well-differentiated Thyroid Cancer
Polo-like kinases (PLKs) are pivotal regulators of cell proliferation and cell survival; therefore, PLKs may be potential targets in the treatment of malignancy. The therapeutic effects of volasertib, a PLKs inhibitor for papillary and follicular thyroid cancer (known as well-differentiated thyroid…
-
Artikel Jurnal Teks lengkap
Association of pregnancy outcomes in women with type 2 diabetes treated with metformin versus insulin when becoming pregnant
BACKGROUND: Metformin use in pregnancy is controversial because metformin crosses the placenta and the safety on the fetus has not been well-established. This retrospective study aimed to compare pregnancy outcomes in women with preexisting type 2 diabetes receiving metformin or standard insulin…